Wrong Metoprolol, a Syncopal Episode, and a PIC Who Wants to "Fix" the File
A 71-year-old woman with atrial fibrillation takes metoprolol tartrate 25 mg twice daily. Nine days ago the pharmacy dispensed metoprolol succinate 50 mg twice daily: at data entry a technician selected the wrong product, and the pharmacist's verification missed the strength and salt-form difference. She presents to the emergency department with dizziness, a heart rate of 42, and a syncopal episode; the ED notes the medication discrepancy. She returns to the pharmacy with the bottle. The pharmacist confirms the error. The pharmacy has a continuous quality improvement program on paper but no written policy, and no events have been logged in two years. The PIC says he will delete the original prescription record and re-enter it correctly "so the inspection file looks clean," and asks whether he has to tell the patient anything.
1. What immediate patient-care and communication steps are required?
Read the worked answer
Patient safety first, and honesty is part of safety:
- Do not dispense anything further until the correct regimen is confirmed with the prescriber - the patient is symptomatic with bradycardia and syncope; the prescriber needs to know what she actually took and for how long.
- Disclose the error to the patient (and, with her authorization, the ED/care team). Explain what happened, what she should do now, and what to watch for (dizziness, worsening bradycardia, syncope). Give a direct contact.
- Retrieve the wrong product, provide the correct product with counseling, and document the exchange.
- Counsel with teach-back on the salt form and strength distinction; look-alike/sound-alike pairs like metoprolol tartrate/succinate are a classic mix-up - flag the patient profile and consider an auxiliary warning label.
- Do not charge for the corrective dispensing, and address any out-of-pocket ED costs as a service-recovery matter.
Apology and explanation are not admissions of liability in the way pharmacists fear; concealment is the far larger exposure.
2. Can the PIC delete and re-enter the original prescription record? What is the correct way to handle the record?
Read the worked answer
No. Deleting and re-entering is falsification of a prescription record. The record must show what actually happened, in the order it happened.
Correct handling:
- Leave the original dispensing record intact. Annotate it - with date, time, and initials - to note the dispensing error, the discovery, the prescriber contact, and the corrective action taken.
- Any subsequent correction is an addendum, clearly identified as such, not a replacement entry.
- Prescription and dispensing records must be retained for the required period (two years for Virginia prescription records and for federal controlled-substance records, longer where the payer or the pharmacy's own policy requires) and must be retrievable for inspection.
- If the pharmacy uses an electronic system that allows "editing" a completed fill, the corrected transaction should generate an audit trail; never use an override that erases the original.
A record showing an error, a disclosure, and a documented corrective action is better at inspection than a suspiciously clean file - and a deleted-then-recreated record is exactly what a Board investigator or plaintiff's expert will characterize as a cover-up.
3. What does Virginia's continuous quality improvement framework require here, and what should the pharmacist report and to whom?
Read the worked answer
Build the record of the quality program, not just of the error.
- Virginia requires pharmacies to maintain a continuous quality improvement (CQI) program for detecting, documenting, and preventing quality-related events, with a written policy, a defined review process, and documentation that the review occurred. A program that exists only on paper and has logged nothing in two years is itself a deficiency.
- This event should be logged as a quality-related event, reviewed with staff (root cause: product selection at data entry, verification technique, look-alike/sound-alike storage), and tied to a corrective action plan with a follow-up date.
- Board reporting: whether a particular event must be reported to the Virginia Board of Pharmacy depends on the event and on current Board regulation and guidance. Do not assume silence is safe - check 18VAC110-20 (and current Board guidance) for reportable events, and consult the Board when in doubt. Patient harm plus an unlogged error plus a paper-only CQI program is a combination that invites a complaint-based investigation regardless.
- Also consider: notification to the prescriber, insurer/payer requirements for a replaced medication, and internal review of the technician's and pharmacist's roles consistent with a just culture - discipline is a separate decision from documentation.
- Never alter the record to avoid a report; that converts a correctable error into a licensure problem for the individual pharmacist.